<?xml version="1.0" ?>
<document id="c59c9a2c6315ed5aa7c437d1943fd94518119fd8">
  <chunk id="c59c9a2c6315ed5aa7c437d1943fd94518119fd8.c0" text="A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax OPEN">
    <entity charOffset="38-46" id="c59c9a2c6315ed5aa7c437d1943fd94518119fd8.c0.e0" ontology_id="GO_0003823" text="Antibody" type="gene_function"/>
    <entity charOffset="38-46" id="c59c9a2c6315ed5aa7c437d1943fd94518119fd8.c0.e1" ontology_id="GO_0042571" text="Antibody" type="gene_function"/>
  </chunk>
  <chunk id="c59c9a2c6315ed5aa7c437d1943fd94518119fd8.c1" text="At a dose of 0.3 mg/kg, it could protect all tested rats from a lethal dose of LeTx. Even administration of 0.6 mg/kg hmPA6 48 h before LeTx challenge protected all tested rats. The results indicate that hmPA6 is a potential candidate for clinical application in anthrax treatment."/>
</document>
